The International Pancreas and Islet Transplant Association

What The International Pancreas and Islet Transplant Association does

The International Pancreas and Islet Transplant Association (IPITA) is a professional medical association dedicated to advancing pancreatic beta cell replacement therapy, including whole pancreas and islet transplantation, for the treatment of diabetes. Headquartered in Montréal, Canada (740 Notre-Dame Ouest, Suite 1245), IPITA operates as an official section of The Transplantation Society (TTS), sharing administrative infrastructure while maintaining scientific autonomy in its domain. Its primary members are transplant surgeons, endocrinologists, clinical researchers, and scientists working on stem-cell-derived beta-cell therapies, bioengineering innovations such as encapsulation devices and 3D bioprinting, and tolerance-inducing immunology strategies. The association's served community includes both practicing clinicians who require standardized Good Practice Guidelines and translational researchers focused on regenerative medicine and curative diabetes strategies.

IPITA's product portfolio centers on educational and scientific exchange infrastructure rather than proprietary technology. Core offerings include the IPITA Education Dashboard, the IPITA Curriculum on Pancreas & Islet Cell Transplantation, a searchable multimedia library of congress recordings and webinars, and Transplantation Direct (the official peer-reviewed journal). The flagship engagement vehicles are biennial international congresses—most recently the 20th World Congress in Pisa (2024) with over 400 delegates, IPITA 2025 in Italy, and IPITA 2027 in Montreal—supplemented by regional Beta Cell Summits and the APITA congress in Asia. Additional collaborative programming includes the AST-TERMIS webinar series.

The organization's revenue model is built on recurring annual membership dues (with 2026 dues currently being collected), congress registration fees, and industry support for educational initiatives. Membership grants access to the membership directory, educational resources, congress recordings, and voting rights in organizational governance. IPITA does not operate as a venture-backed or publicly traded entity; it is governed by a council and led by President Lorenzo Piemonti (Italy), with funding flowing through member contributions and event sponsorship rather than external investment.

Name

The International Pancreas and Islet Transplant Association

Legal name

International Pancreas & Islet Transplant Association

Website

https://ipita.org

Company type

Private

Operating status

Operating

Headcount range

501–1,000 employees

Short description

IPITA is a global professional medical association serving transplant surgeons, endocrinologists, and diabetes researchers focused on pancreatic beta cell replacement therapies, including pancreas and islet transplantation and emerging stem-cell-derived treatments.

Ownership category

akta.pro rank

Headquarters

HQ city

Montréal

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership Dues and Subscriptions: Annual membership dues supporting association operations, with members paying 2026 dues for access to member-exclusive resources including congress recordings, the membership directory, and educational materials.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

The International Pancreas and Islet Transplant Association (IPITA) is a global professional medical association that serves transplant surgeons, endocrinologists, and diabetes/regenerative medicine researchers through paid membership, biennial international congresses, regional scientific meetings (e.g., APITA, Beta Cell Summits), the official journal Transplantation Direct, and a structured educational curriculum with a searchable multimedia library on pancreas and islet cell transplantation.

Product overview

IPITA is a professional medical association serving the global pancreas and islet transplant community. The organization offers a unified suite of member services including the Education Dashboard as a central hub, complemented by a searchable multimedia library and structured curriculum for professional development in pancreas and islet cell transplantation. The association publishes the official journal Transplantation Direct and organizes international congresses including the triennial World Congress, regional APITA congresses, and Beta Cell Summits. Additional offerings include video testimonials, the AST-TERMIS collaborative webinar series, and membership services with directory, profile, and voting capabilities. All services are primarily accessible to members of the professional association.

Differentiator

Problem solved

Functional benefit

Products and services

• IPITA Membership Annual professional membership for transplant surgeons, endocrinologists, and researchers, providing access to the membership directory, member-exclusive resources, congress recordings, voting rights in organizational governance, and reduced registration rates for IPITA congresses.
• IPITA International Congresses and Meetings Biennial world congresses (IPITA 2025 in Italy, IPITA 2027 in Montreal) and regional meetings including Beta Cell Summits and the IPITA-IXA-CTRMS joint congress, providing scientific exchange, keynote sessions, and professional networking for transplant professionals and researchers worldwide.
• IPITA Educational Resources Education Dashboard, structured IPITA Curriculum on Pancreas & Islet Cell Transplantation, and a searchable multimedia library of recorded congress sessions and webinars, offered as professional development content for transplant clinicians and researchers.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered core, major and minor.

• Asian Pancreas and Islet Transplant Association (APITA)coreStrategic or Co-development Partner · 23 October 2026Regional partnership for joint scientific collaboration. IPITA members are invited to the 5th Congress of APITA taking place October 23, 2026, in Busan, Korea, facilitating cross-regional knowledge exchange and professional networking.
• Breakthrough T1DmajorStrategic or Co-development Partner · 9 October 2026Breakthrough T1D (formerly JDRF) is hosting the inaugural Breakthrough T1D Clinical & Research Congress (CRC 2026) in Philadelphia, PA, October 9-11, 2026. IPITA members are invited to participate, reflecting shared mission in diabetes research and type 1 diabetes cure strategies.
• The Transplantation Society (TTS)coreStrategic or Co-development PartnerIPITA operates as an official section of The Transplantation Society, sharing administrative infrastructure including the Montreal-based headquarters, staff directory, and digital platform. TTS provides operational support while IPITA maintains scientific autonomy in pancreas and islet transplantation matters.
• AST-TERMISminorStrategic or Co-development PartnerCollaborative webinar series partnership with American Society of Transplantation (AST) and Tissue Engineering and Regenerative Medicine International Society (TERMIS), providing joint educational programming for members.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• The Transplantation Society (TTS): The umbrella parent organization of which IPITA is an official section. TTS is the most direct peer — same Montreal headquarters, shared staff and platform, and same transplantation professional-association mission at a broader scope.
• International Xenotransplantation Association (IXA): Another official TTS section alongside IPITA focused on xenotransplantation. Comparable professional-association structure, including congresses, guidelines, and member dues within TTS's umbrella.
• International Society for Heart and Lung Transplantation (ISHLT): A global professional society for heart and lung transplantation offering a comparable suite of congresses, guidelines, journals, and educational resources — a direct functional analog to IPITA in a different organ niche.
• European Society for Organ Transplantation (ESOT): European counterpart transplant professional society hosting congresses and educational programming comparable to IPITA's. Overlapping mission around advancing transplantation science and harmonizing clinical practice.
• American Society of Transplant Surgeons (ASTS): U.S. society for transplant surgeons, addressing a closely overlapping surgeon-persona member base as IPITA. Comparable structure: membership dues, annual congress, and clinical practice guidelines.
• American Society of Transplantation (AST): A leading U.S.-based professional society for transplantation professionals. AST is a co-partner with IPITA in the AST-TERMIS webinar series and serves a highly overlapping membership of transplant clinicians and researchers.
• International Liver Transplantation Society (ILTS): Another official section of TTS alongside IPITA, focused on liver transplantation. Operates with an analogous professional-association model — congresses, guidelines, journals, and member dues — making it a structurally close peer.
• The International Society for Organ Donation and Procurement (ISODP): Another TTS section dedicated to organ donation and procurement. Structurally analogous to IPITA — shared platform, shared staff, comparable member services — making it a close operational peer within the same parent society.

Emerging players

• Breakthrough T1D (formerly JDRF): Major diabetes research funder co-hosting the inaugural CRC 2026 Congress with IPITA. Overlaps with IPITA's mission on Type 1 diabetes cure strategies and brings significant funding reach into beta-cell replacement research.
• International Society for Stem Cell Research (ISSCR): Global stem cell research society whose mission intersects IPITA's regenerative-medicine focus as stem-cell-derived beta-cell therapies advance. Comparable educational and guideline-setting role in adjacent scientific territory.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/ipita_yic
• LinkedInlinkedin.com/company/ipita

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The International Pancreas and Islet Transplant Association